Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about HNRNPA2B1: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
| Gene Symbol | HNRNP-A2B1 |
| Full Name | Heterogeneous Nuclear Ribonucleoprotein A2/B1 (HNRNPA2B1) |
| Aliases | HNRNPA2B1 |
| Protein Type | Gene |
| Target Class | Other |
| Function | Gene Symbol: HNRNPA2B1 |
| Mechanism of Action | Therapeutic agents targeting HNRNPA2B1 would work by modulating its RNA-binding activity, preventing pathological protein aggregation, or reducing the formation of cytoplasmic inclusions associated with neurodegeneration. These drugs could utilize antisense oligonucleotides to reduce HNRNPA2B1 expression or small molecules to inhibit its protein-protein interactions and RNA-binding functions. |
| Druggability | Low (0.35) |
| Clinical Stage | Phase II |
| Molecular Weight | 37 kDa |
| Amino Acids | 353 aa |
| NCBI Gene ID | Search NCBI |
| GeneCards | HNRNP-A2B1 |
| Human Protein Atlas | HNRNP-A2B1 |
| Associated Diseases | ALS, Alzheimer's Disease, Amorphous Aggregates, Amyotrophic Lateral Sclerosis, Cancer |
| Known Drugs/Compounds | G-Quadruplex Structured Dna, Single-Stranded Dna, Ionic Strength, Irinotecan, Viral Genome G-Quadruplex |
| Interactions | IGF2BP1, CSNK2A1, NOTCH1, JUN, RANK, RANKL |
| SciDEX Target | View Target Profile (1 clinical trials) |
| SciDEX Hypotheses | Axonal RNA Transport Reconstitution |
| KG Connections | 421 knowledge graph edges |
| Databases | GeneCardsUniProtHPASTRING |
Knowledge base pages for this entity
flowchart TD
HNRNPA2B1["HNRNPA2B1<br/>RNA-binding protein<br/>Ribonucleoprotein"]
%% RNA Processing & Associated Proteins
HNRNPA1["HNRNPA1<br/>RNA-binding protein"]
IGF2BP1["IGF2BP1<br/>RNA-binding protein"]
VALOSIN["VCP/VALOSIN<br/>Protein processing"]
%% Signaling Pathways
NOTCH1["NOTCH1<br/>Transcription factor"]
NotchPath["Notch Signaling<br/>Pathway"]
CSNK2A1["CSNK2A1<br/>Casein kinase"]
EpiPath["Epigenetic<br/>Regulation"]
%% Neurodegenerative Diseases
ALS["Amyotrophic Lateral<br/>Sclerosis (ALS)"]
FTD["Frontotemporal<br/>Dementia"]
ALZ["Alzheimer's<br/>Disease"]
MS["Multiple<br/>Sclerosis"]
Dementia["Dementia<br/>General"]
NeuroDegeneration["Neurodegeneration<br/>Process"]
%% Inflammatory Process
Inflammation["Neuroinflammation<br/>Process"]
%% Connections
HNRNPA2B1 --|"associates with"|--> HNRNPA1
HNRNPA2B1 --|"interacts with"|--> IGF2BP1
HNRNPA2B1 --|"associates with"|--> VALOSIN
HNRNPA2B1 --|"activates"|--> CSNK2A1
HNRNPA2B1 --|"activates"|--> NOTCH1
HNRNPA2B1 --|"activates"|--> NotchPath
HNRNPA2B1 --|"inhibits"|--> EpiPath
HNRNPA2B1 --|"activates"|--> ALS
HNRNPA2B1 --|"activates"|--> ALZ
HNRNPA2B1 --|"associated with"|--> FTD
HNRNPA2B1 --|"activates"|--> MS
HNRNPA2B1 --|"associated with"|--> Dementia
HNRNPA2B1 --|"activates"|--> NeuroDegeneration
HNRNPA2B1 --|"regulates"|--> Inflammation
Inflammation --|"contributes to"|--> NeuroDegeneration
NotchPath --|"promotes"|--> NeuroDegeneration
CSNK2A1 --|"phosphorylates"|--> HNRNPA2B1
%% Styling
style HNRNPA2B1 fill:#006494
style HNRNPA1 fill:#4a1a6b
style IGF2BP1 fill:#4a1a6b
style VALOSIN fill:#4a1a6b
style NOTCH1 fill:#4a1a6b
style NotchPath fill:#ef5350
style CSNK2A1 fill:#4a1a6b
style EpiPath fill:#1b5e20
style ALS fill:#5d4400
style FTD fill:#5d4400
style ALZ fill:#5d4400
style MS fill:#5d4400
style Dementia fill:#5d4400
style NeuroDegeneration fill:#ef5350
style Inflammation fill:#ef5350| Target | Relation | Type | Str |
|---|---|---|---|
| Rna Maturation | involved_in | process | 0.95 |
| Mrna Transport | involved_in | process | 0.95 |
| Liquid-Liquid Phase Separation | involved_in | process | 0.95 |
| Dynamic Liquid-Like Droplets | associated_with | phenotype | 0.95 |
| Rna Binding | involved_in | process | 0.95 |
| GPX4 | associated_with | protein | 0.93 |
| m6A methyladenosine reader | involved_in | mechanism | 0.92 |
| Protein Aggregation | contributes_to | process | 0.92 |
| TAU | associated_with | protein | 0.90 |
| Multisystem Proteinopathy | causes | disease | 0.90 |
| Membraneless Organelles | contributes_to | cell_type | 0.90 |
| Pathogenic Protein Aggregates | associated_with | phenotype | 0.90 |
| Rna Recognition Domain | associated_with | protein | 0.90 |
| Intrinsically Disordered Low-Complexity Domain | associated_with | mechanism | 0.90 |
| G-Quadruplex Structured Dna | binds | compound | 0.90 |
| Nucleic Acid Metabolism | regulates | process | 0.90 |
| Ferroptosis | protects_against | process | 0.89 |
| Amorphous Aggregates | associated_with | phenotype | 0.88 |
| Tau Protein Toxicity | associated_with | phenotype | 0.85 |
| HSPA8 mRNA Dendritic Localization | regulates | process | 0.85 |
| Rna Stress Granule Function | regulates | process | 0.85 |
| Hspa8 Mrna Localization | regulates | process | 0.85 |
| Low-Complexity Domain | interacts_with | biomarker | 0.85 |
| RNA Stress Granule | involved_in | process | 0.85 |
| Mrnas In Gabaergic Neurons | regulates | biomarker | 0.85 |
| Tumorigenesis | involved_in | process | 0.85 |
| Single-Stranded Dna | binds | compound | 0.85 |
| Cancer | implicated_in | disease | 0.85 |
| Viral Infection | involved_in | process | 0.85 |
| Tau Toxicity | associated_with | mechanism | 0.80 |
| Mrna Localization | involved_in | process | 0.80 |
| DNAJB6 | genetically_interacts | gene | 0.80 |
| Nuclear Dna Sensing | mediates | process | 0.80 |
| Alzheimer's Disease | associated_with | disease | 0.80 |
| axonal_RNA_transport | mediates | pathway | 0.80 |
| Alzheimer's Disease Neurodegeneration | contributes_to | disease | 0.75 |
| Anticancer Activity | contributes_to | mechanism | 0.75 |
| Antiviral Function | mediates | process | 0.75 |
| Spinal Muscular Atrophy | associated_with | disease | 0.65 |
| Cancer | therapeutic_target | disease | 0.65 |
| Ms | therapeutic_target | disease | 0.65 |
| Als | interacts_with | disease | 0.65 |
| Inflammation | regulates | disease | 0.65 |
| Ms | regulates | disease | 0.65 |
| Diabetes | regulates | disease | 0.65 |
| Neurodegeneration | associated_with | disease | 0.65 |
| Ms | associated_with | disease | 0.65 |
| Dementia | associated_with | disease | 0.65 |
| Als | associated_with | disease | 0.65 |
| Neurodegeneration | activates | disease | 0.65 |
| Source | Relation | Type | Str |
|---|---|---|---|
| CBL | degrades | protein | 0.92 |
| LNK | regulates | protein | 0.90 |
| Irinotecan | interacts_with | drug | 0.90 |
| h-8196b893 | targets_gene | hypothesis | 0.90 |
| Ionic Strength | modulates | compound | 0.85 |
| Ph | modulates | compound | 0.85 |
| Cgg Repeat Rna | binds | variant | 0.85 |
| h-8196b893 | targets | hypothesis | 0.80 |
| Viral Genome G-Quadruplex | interacts_with | compound | 0.80 |
| Irinotecan | inhibits | drug | 0.75 |
| CD36 | regulates | gene | 0.60 |
| SIRT6 | inhibits | gene | 0.60 |
| OPTN | associated_with | gene | 0.60 |
| VCP | associated_with | gene | 0.60 |
| SQSTM1 | associated_with | gene | 0.60 |
| TIA1 | associated_with | gene | 0.60 |
| VCP | contributes_to | gene | 0.60 |
| JUN | activates | gene | 0.60 |
| SQSTM1 | contributes_to | gene | 0.60 |
| RANK | activates | gene | 0.60 |
| RANKL | activates | gene | 0.60 |
| TIA1 | contributes_to | gene | 0.60 |
| GAIN | activates | gene | 0.60 |
| HNRNPA1 | associated_with | gene | 0.60 |
| HNRNPA1 | contributes_to | gene | 0.60 |
| CSNK2A1 | associated_with | gene | 0.60 |
| IGF2BP1 | interacts_with | gene | 0.60 |
| HNRNPA1 | degrades | gene | 0.60 |
| VALOSIN | associated_with | gene | 0.60 |
| OPTN | degrades | gene | 0.60 |
| OPTINEURIN | degrades | gene | 0.60 |
| SQSTM1 | degrades | gene | 0.60 |
| TIA1 | degrades | gene | 0.60 |
| CSNK2A1 | activates | gene | 0.60 |
| NOTCH1 | activates | gene | 0.60 |
| TAU | activates | gene | 0.60 |
| YES1 | activates | gene | 0.60 |
| SOX9 | activates | gene | 0.60 |
| HNRNPA1 | causes | entity | 0.60 |
| OPTINEURIN | associated_with | gene | 0.60 |
| TAF15 | inhibits | gene | 0.60 |
| DNAJB6 | interacts_with | gene | 0.60 |
| TDP-43 | associated_with | gene | 0.60 |
| ATXN2 | associated_with | gene | 0.60 |
| CNTN4 | expressed_in | gene | 0.60 |
| PLIN4 | expressed_in | gene | 0.60 |
| BID | expressed_in | gene | 0.60 |
| TBC1D24 | expressed_in | gene | 0.60 |
| FUS | associated_with | gene | 0.60 |
| HNRPU | inhibits | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| Axonal RNA Transport Reconstitution | 0.446 | neurodegeneration | RNA binding protein dysregulation across |
Scientific analyses that reference this entity
neurodegeneration | 2026-04-01 | 7 hypotheses Top: 0.490
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| SIRT6-regulated macrophage efferocytosis epigenetically controls inflammation re [PMID:36593966] | Li B, Xin Z, Gao S, Li Y, Guo S, Fu Y, X | Theranostics | 2023 | 1 |
| Multisystem proteinopathy: Where myopathy and motor neuron disease converge. [PMID:33145792] | Korb MK, Kimonis VE, Mozaffar T | Muscle Nerve | 2021 | 1 |
| The role of m6A modification in the biological functions and diseases. [PMID:33611339] | Jiang X, Liu B, Nie Z, Duan L, Xiong Q, | Signal Transduct Target Ther | 2021 | 1 |
| Tumor-derived exosomal miR-934 induces macrophage M2 polarization to promote liv [PMID:33213490] | Senlin Zhao, Yushuai Mi, Bingjie Guan, B | Journal of hematology & oncolo | 2020 | 1 |
| Rare Inherited forms of Paget's Disease and Related Syndromes. [PMID:30756140] | Ralston SH, Taylor JP | Calcif Tissue Int | 2019 | 1 |
| A LNK-CBL-HNRPA2B1-GPX4 signaling axis mediates dopaminergic neuron vulnerabilit [PMID:41616574] | ["Liu Z", "Wang R", "Shen M", "Lan X", " | Redox biology | 2026 | 0 |
| Human papillomavirus 16 E6 oncoprotein promotes up-regulation of RNA-binding pro [PMID:41725810] | ["Cerasuolo A", "Pecchillo Cimmino T", " | Frontiers in microbiology | 2026 | 0 |
| Molecular recognition and induced dimerization of hnRNP A2/B1 truncations by G-q [PMID:41888191] | ["Shahatibieke D", "Tang X", "Zheng X", | Scientific reports | 2026 | 0 |
| Coordinated Post-Transcriptional Regulation facilitates PD-L1 protein production [PMID:41936857] | Chen R, Rajasekaran S, Xing X, Zhang Q, | Cancer Lett | 2026 | 0 |
| LncRNA 4930544M13Rik-201 regulates CACNA2D1 expression via interacting with hnRN [PMID:41864512] | Fang Z, Liu F, Tang Q, Liu Y, Peng Y, Zh | Brain research bulletin | 2026 | 0 |
| Comparative Binding Analysis by Computational Methods and Quartz Crystal Microba [PMID:41728844] | ["Volkova O", "Serova A", "Kravtsov V", | Journal of chemical informatio | 2026 | 0 |
| Functional Variants of the RAD51 Gene Contribute to Susceptibility to Non-Syndro [PMID:41918261] | Guo S, Guo T, Xu Y, Chen R, Wang X | Orthodontics & craniofacial re | 2026 | 0 |
| Ligand-specific conformational dynamics and interaction landscapes of hnRNPA2B1 [PMID:41853685] | Zhou Z, Li Y, Yang P, Zhu R, Li J, Wu B, | Current research in structural | 2026 | 0 |
| Neddylation-Mediated hnRNPA2B1 Degradation Aggravates Retinal Endothelial Cell D [PMID:41773772] | Chen TR, Zhou JX, Hou YR, Zhang YN, Li C | Investigative ophthalmology & | 2026 | 0 |
| Mechanistic studies on HNRNPA2B1 suggest binding but not selective recognition o [PMID:41662154] | ["Park R", "Demny M", "Miller L", "Pedra | RNA biology | 2026 | 0 |
| Network medicine modeling of the m⁶A regulatory landscape identifies a KLF6-WTAP [PMID:41787499] | Xu C, Zhou Z, Lin Y, Zhang S, Cai S, Li | Journal of translational medic | 2026 | 0 |
| Integrative transcriptome-wide association analyses reveal PRKCG-linked GABAergi [PMID:41507195] | ["Jin Y", "Cao Y", "Ma W", "Li R", "Li Y | Nature communications | 2026 | 0 |
| The Intersection of m6A Methylation and Immune Response in PCOS: A Bioinformatic [PMID:41725222] | ["Xu W", "Shi L", "Lu A", "Cui L", "Qian | Immunity, inflammation and dis | 2026 | 0 |
| Expression, purification, and biophysical characterization of liquid-liquid phas [PMID:41297573] | ["Dur\u00e1n-Armenta L", "Meszaros A", " | Protein expression and purific | 2026 | 0 |
| Interaction of tau with HNRNPA2B1 and N6-methyladenosine RNA mediates the progre [PMID:34453888] | Jiang L, Lin W, Zhang C, Ash PEA, Verma | Molecular cell | 2021 | 0 |